Abstract.
A patient with hypocalcemia and hypomagnesemia, and renal wasting of both cations, is presented. This patient had a dramatic calcium response to treatment with spironolactone. The possible diagnoses and mechanisms of response are discussed. It is concluded that the patient had a calcium-sensing receptor mutation, and that treatment with spironolactone induced an effect on renal handling of calcium in this condition. It is suggested that this treatment be tried in other similar patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: July 27, 2001 / Accepted: December 7, 2001
About this article
Cite this article
Al-Gharabally, A., Doi, S. & Al-Shoumer, K. Spironolactone for the treatment of hypercalciuric hypocalcemia. J Bone Miner Metab 20, 243–247 (2002). https://doi.org/10.1007/s007740200036
Issue Date:
DOI: https://doi.org/10.1007/s007740200036